tiprankstipranks
Trending News
More News >
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
Advertisement

Gain Therapeutics (GANX) Technical Analysis

Compare
301 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Gain Therapeutics’s (GANX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Gain Therapeutics is a Sell.
Gain Therapeutics’s (GANX) 20-Day exponential moving average is 1.72, while Gain Therapeutics’s (GANX) share price is $1.73, making it a Buy.
Gain Therapeutics’s (GANX) 50-Day exponential moving average is 1.72, while Gain Therapeutics’s (GANX) share price is $1.73, making it a Buy.

Gain Therapeutics (GANX) Pivot Points

Sep 27, 2025, 12:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.55
1.62
1.67
1.74
1.79
1.86
1.91
Fibonacci
1.62
1.66
1.69
1.74
1.78
1.81
1.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gain Therapeutics (GANX) Moving Averages

Sep 27, 2025, 12:20 PM
Period
Simple
Exponential
MA5
1.75Buy
1.74Buy
MA10
1.69Buy
1.72Buy
MA20
1.74Buy
1.72Buy
MA50
1.68Buy
1.72Buy
MA100
1.75Buy
1.76Buy
MA200
1.90Sell
1.88Sell
Gain Therapeutics’s (GANX) 10-Day exponential moving average is 1.72, while Gain Therapeutics’s (GANX) share price is $1.73, making it a Buy.
Gain Therapeutics’s (GANX) 100-Day exponential moving average is 1.76, while Gain Therapeutics’s (GANX) share price is $1.73, making it a Buy.
Gain Therapeutics’s (GANX) stock price is $1.73 and Gain Therapeutics’s (GANX) 50-day simple moving average is 1.68, creating a Buy signal.
Gain Therapeutics’s (GANX) stock price is $1.73 and Gain Therapeutics’s (GANX) 100-day simple moving average is 1.75, creating a Buy signal.
Gain Therapeutics’s (GANX) stock price is $1.73 and Gain Therapeutics’s (GANX) 200-day simple moving average is 1.90, creating a Sell signal.

Gain Therapeutics (GANX) Technical Indicators

Sep 27, 2025, 12:20 PM
Name
Value
Implied Action
RSI (14)
54.60
Neutral
STOCH (9,6)
62.24
Neutral
STOCHRSI (14)
62.24
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
16.61
Buy
Williams %R
-25.89
Buy
CCI (14)
12.18
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
49.66
Neutral
ROC
2.29
Buy
Gain Therapeutics’s (GANX) Relative Strength Index (RSI) is 54.60, creating a Neutral signal.
Gain Therapeutics’s (GANX) Trend Strength Indicator (ADX) is 16.61, creating a Buy signal.
Gain Therapeutics’s (GANX) Commodity Channel Index (CCI) is 12.18, creating a Neutral signal.
Gain Therapeutics’s (GANX) Price Rate of Change (ROC) is 2.29, creating a Buy signal.

FAQ

Is GANX a Buy, Hold, or Sell?
Based on GANX’s technical indicators, GANX is a Buy.
    What is GANX’s RSI (14)?
    GANX’s RSI (14) is 54.60, which suggests GANX is a Neutral.
      What is GANX’s MACD?
      GANX’s MACD is <0.01, which suggests GANX is a Sell.
        What is GANX’s 5-day moving average?
        GANX’s 5-day moving average is 1.75, which suggests GANX is a Buy.
          What is GANX’s 20-day moving average?
          GANX 20-day moving average is 1.74, which suggests GANX is a Buy.
            What is GANX’s 50-day moving average?
            GANX’s 50-day moving average is 1.68, which suggests GANX is a Buy.
              What is GANX’s 200-day moving average?
              GANX’s 200-day moving average is 1.90, which suggests GANX is a Sell.
                What is GANX’s Williams % R (14)?
                GANX’s Williams % R (14) is -25.89, which suggests GANX is a Buy.
                  What is GANX’s CCI (14)?
                  GANX’s CCI (14) is 12.18, which suggests GANX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis